Single Upfront Genomic Test Improves Lynch Syndrome Detection Rates

Single Upfront Genomic Test Improves Lynch Syndrome Detection Rates

APRIL 02, 2018

COLUMBUS, OHIO – A single, upfront genomic test is more effective for detecting Lynch syndrome in colorectal cancer (CRC) patients than the traditional multiple, sequential testing approach, according to new clinical data reported by The Ohio State University Comprehensive Cancer Center ­– Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).